Stopping the spread of the novel coronavirus and protecting the public is one of the world’s foremost priorities. Fortunately, MAKO Medical Laboratories, a national reference laboratory and leader in testing, is stepping up to the mark. Having handled millions of COVID-19 tests, the healthcare brand is greatly helping the global fight against the pandemic. Let’s delve into how the company is protecting American families.
Expansion of the Testing Lab Capacity
Accredited by the College of American Pathologists (CAP), MAKO Medical Laboratories has been leading the way when it comes to COVID-19 testing. Toward the start of the pandemic in 2020, CEO Chad Price switched the primary focus of the nationally recognized testing lab to the COVID-19 outbreak. The company operates more than 70,000 square feet across two North Carolina-based facilities.
As a direct response to the novel coronavirus outbreak, the company expanded the Henderson facility. This change gave the laboratory extra space and, in turn, a larger testing capacity than before. The laboratory is now able to test over 150,000 samples per day. Additionally, Chad Price made a move toward expanding the company’s staff. Between 2020 and 2021, the MAKO Medical team expanded from 350 employees to more than 1,000 employees. The swift action taken after the outbreak has allowed the company to excel in testing.
Aside from testing capabilities, MAKO Medical Laboratories has begun identifying the various mutations of the virus. Utilizing industry-leading testing assays, the team of researchers can quickly recognize and track variants of the novel coronavirus. The assays that MAKO Medical currently uses include the Applied Biosystems TaqPath COVID-19 Combo Assay.
Additionally, the national reference laboratory uses the Next Generation Sequencing (NGS) research panel. The panel allows researchers to map more than 99% of the SARS-Cov-2 genome and identify most of the variants as they appear within samples. The innovative platform is used by some of the world’s leading experts. MAKO Medical Laboratories were among the research companies to identify the B.1.1.7 variant of the virus as well as further mutations as they come to light.
Cost-Effective COVID-19 Antigen Tests
Earlier this year, MAKO Medical Laboratories introduced a highly sensitive, cost-effective antigen test. The tests can accurately identify the SARS-CoV-2 N protein antigen, which tends to be detectable during the acute phase of the COVID-19 virus in people. In simple terms, the DiaSorin LIAISON® SARS-CoV-2 Ag high-throughput antigen test means that experts can quickly identify the virus in patients.
“Our MAKO team is excited to partner with Diasorin to bring this highly sensitive antigen test to the masses,” said Josh Arant, COO, and Co-Founder at MAKO Medical Laboratories. “With a sensitivity of 97.1% and a specificity of 100%, utilizing nasal and nasopharyngeal swabs, MAKO can turn results around in less than 24 hours with a capacity to run over 100,000 tests per day.”
The move allowed MAKO Medical Laboratories to offer mass testing to North Carolina residents. In addition to identifying the virus in patients, the test also allows experts to determine whether someone who previously had COVID-19 is carrying it. This information could help stop the spread of the virus and protect people in the area.
“DiaSorin’s platform demonstrates the next level of understanding for COVID-19 cases, and it allows our team to further our partnership with health officials across the country as a one-stop laboratory service provider,” said Arant when the announcement of the new, affordable test option was first announced.
More than Seven Million Tests Completed
Since the pandemic began and MAKO Medical Laboratories switched its focus to COVID-19 testing, the company has seen huge amounts of success. To date, the two testing laboratories have processed more than seven million tests to ensure the safety and protection of the public. Thanks to the expansion of the testing laboratories and the boost in staff members, the company now has a massive capacity for virus testing.
However, it doesn’t end there. MAKO Medical Laboratories has played a central role in identifying new strains of the virus. In May 2021, the testing lab established a partnership with the Centers for Disease Control and Prevention (CDC) to offer continuous information based on next-generation sequencing of SARS-CoV-2. Using cutting-edge sequencing techniques, the researchers can offer invaluable information that will help stop the spread of the virus in the months to come.
“Over the past several months, our sequencing team has identified the emergence of strains like the United Kingdom B.1.1.7, South African, and Denmark variants in states across the country,” said Steve Hoover, Vice President of Laboratory Operations, MAKO Medical. “As new strains are defined, MAKO continues to sequence samples and provide much-needed data to public health professionals.”
As the fight against the pandemic continues, Chad Price and MAKO Medical Laboratories are dedicated to continuing their testing and research efforts. The leading North Carolina healthcare brand is playing a central role when it comes to protecting American families and beating the COVID-19 outbreak.
About MAKO Medical Laboratories
Boasting an expert team of nationally recognized doctors and PhDs, MAKO Medical Laboratories specializes in methodology development and pathological services. The national reference laboratory and leader in COVID-19 testing prioritize patients by offering transparency.
Founded in 2014 by Chad Price, Adam Price, and Josh Arant, the healthcare brand aims to disrupt the sector while offering support to veterans via employment opportunities. The company combines a wealth of new technology including robotics, app platforms, and cloud-based tech. In response to the COVID-19 pandemic, the laboratories have adapted their services to offer accurate testing.
Chad Price is the CEO of MAKO Medical Laboratories. He has had a long entrepreneurial career previously co-founding BrideGenie and founding Element Services Group Mechanical LLC. He has played a major role in starting Cary Reconstruction and is a board member for Trill A.I. Moreover, he currently offers tailored consulting services to companies embarking on new mergers or primed for growth.